Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debjeet Sur

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Current Diabetes Reviews|May 16, 2022
Pathophysiology Associated with Diabetes-induced Tauopathy and Development of Alzheimer's DiseasePoulami Sarkar, Sarmin Banu, Sanchari Bhattacharya, et al.
Current Pharmaceutical Design|April 13, 2026
Bromocriptine Attenuated Ulcerative Colitis and Colonic Inflammation by Inhibiting IL-1β, Likely through NF-κB Down-regulation: Integrated Network Pharmacology and in vivo Experimental ValidationSarthak Saha, Sourav Mondal, Oishani Chatterjee, et al.
Inflammopharmacology|February 24, 2023
Attenuation of COX-2 enzyme by modulating H<sub>2</sub>O<sub>2</sub>-mediated NF-κB signaling pathway by monoamine oxidase inhibitor (MAOI): a further study on the reprofiling of MAOI in acute inflammationDebjeet Sur, Chaitali Mondal, Ashok Kumar Balaraman, et al.
Inflammopharmacology|March 10, 2022
Repurposing monoamine oxidase inhibitors (MAOI) for the treatment of rheumatoid arthritis possibly through modulating reactive oxidative stress mediated inflammatory cytokinesDebjeet Sur, Arpan Dutta, Chaitali Mondal, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Current Diabetes Reviews|May 16, 2022
Pathophysiology Associated with Diabetes-induced Tauopathy and Development of Alzheimer's DiseasePoulami Sarkar, Sarmin Banu, Sanchari Bhattacharya, et al.
Current Pharmaceutical Design|April 13, 2026
Bromocriptine Attenuated Ulcerative Colitis and Colonic Inflammation by Inhibiting IL-1β, Likely through NF-κB Down-regulation: Integrated Network Pharmacology and in vivo Experimental ValidationSarthak Saha, Sourav Mondal, Oishani Chatterjee, et al.
Inflammopharmacology|February 24, 2023
Attenuation of COX-2 enzyme by modulating H<sub>2</sub>O<sub>2</sub>-mediated NF-κB signaling pathway by monoamine oxidase inhibitor (MAOI): a further study on the reprofiling of MAOI in acute inflammationDebjeet Sur, Chaitali Mondal, Ashok Kumar Balaraman, et al.
Inflammopharmacology|March 10, 2022
Repurposing monoamine oxidase inhibitors (MAOI) for the treatment of rheumatoid arthritis possibly through modulating reactive oxidative stress mediated inflammatory cytokinesDebjeet Sur, Arpan Dutta, Chaitali Mondal, et al.
Pageof 2